Joseph C. Galante - 01 Nov 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Joseph C. Galante by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
01 Nov 2021
Net transactions value
+$753
Form type
4
Filing time
03 Dec 2021, 16:13:25 UTC
Previous filing
05 Nov 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $379 +142 +0.32% $2.67 43,919 01 Nov 2021 Direct F1
transaction CPIX Common Stock Purchase $373 +142 +0.32% $2.63 44,061 02 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.